BI
BVF Inc Portfolio holdings
AUM
$2.8B
This Quarter Return
-17.58%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$495M
AUM Growth
+$495M
(-13%)
Cap. Flow
+$20.2M
Cap. Flow
% of AUM
4.08%
Top 10 Holdings %
Top 10 Hldgs %
75.58%
Holding
34
New
4
Increased
10
Reduced
5
Closed
7
Top Buys
| 1 |
Ironwood Pharmaceuticals
IRWD
|
$28.2M |
| 2 |
CASC
Cascadian Therapeutics, Inc.
CASC
|
$18.1M |
| 3 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
$14.6M |
| 4 |
VTAE
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
|
$8.49M |
| 5 |
Xenon Pharmaceuticals
XENE
|
$2.95M |
Top Sells
| 1 |
Gyre Therapeutics
GYRE
|
$26.3M |
| 2 |
Exelixis
EXEL
|
$10.4M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$9.68M |
| 4 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$5.98M |
| 5 |
CNCE
Concert Pharmaceuticals, Inc.
CNCE
|
$5M |
Sector Composition
| 1 | Healthcare | 62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Achieve Life Sciences
ACHV
$152M
| – | – | -1,020,108 | Closed | -$2.38M |
|
27
Astria Therapeutics
ATXS
$349M
| – | – | -225,000 | Closed | -$2.75M |
|
|
28
Exelixis
EXEL
$10.1B
| – | – | -2,766,152 | Closed | -$10.4M |
|
|
ATYR
29
aTyr Pharma
ATYR
$527M
| – | – | -134,725 | Closed | -$2.5M |
|
|
SGEN
30
DELISTED
Seagen Inc. Common Stock
SGEN
| – | – | -200,000 | Closed | -$9.68M |
|
|
FPRX
31
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| – | – | -240,597 | Closed | -$5.98M |
|
|
AKAO
32
DELISTED
Achaogen, Inc.
AKAO
| – | – | -106,700 | Closed | -$643K |
|